Palickova, Monika <br/><br/>
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.  [electronic resource] 

 -  Leukemia & lymphoma  Sep 2013 
 - 2081-2 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2012.762514  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Etoposide--therapeutic use<br/>Female<br/>Hodgkin Disease--complications<br/>Humans<br/>Lymph Nodes--pathology<br/>Lymphoma, Large B-Cell, Diffuse--complications<br/>Prednisone--therapeutic use<br/>Procarbazine--therapeutic use<br/>Remission Induction<br/>Rituximab<br/>Treatment Outcome<br/>Vincristine--therapeutic use